41 patents currently held
10 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
9 more records may belong here and await a decision; they are not counted.
The next term ends in Oct 2027. from the record
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
2
Ending by 2030
Oct 2027
Next term end
16
Patent families
When these terms end
Held patents by the year their term ends
notable patents
fee due within 90 days
all others
Updated Nov 14, 2026 · includes USPTO assignment & status data published Nov 14, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Notable: the highest-ranked patents in this portfolio by citations and family size. Fee due within 90 days: a maintenance fee is due within 90 days of when this page was computed and not yet paid.
Notable patents
Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Notable
Ends Dec 2036 · Medium confidence
Also notable
Ends Mar 2033 · High confidence
Also notable
Ends Mar 2033 · High confidence
Zika Virus Vaccine
US 11,219,681
Cited by 13 later US patents, top 10% of utility patents granted in 2022 in our data. Protection runs to 2036.
Mutant Fragments of Ospa and Methods and Uses Relating Thereto
US 11,572,392
Cited by 7 later US patents, top 10% of utility patents granted in 2023 in our data. Protection runs to 2033. A terminal disclaimer caps this term to an earlier patent's.
Mutant Fragments of Ospa and Methods and Uses Relating Thereto
US 11,208,439
Cited by 12 later US patents, top 25% of utility patents granted in 2021 in our data. Protection runs to 2033. A terminal disclaimer caps this term to an earlier patent's.
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 2 fees due Jul 21 to 28, 2027 · next Jul 21
- 1 fee due Aug 16, 2027The maintenance fee for Generation of Duck Cell Lines (US 9,260,694) comes due Aug 16, 2027. Unpaid by Feb 16, 2028, it lapses early.
- 1 fee due Oct 9, 2027The maintenance fee for Zika Virus Vaccine (US 11,951,163) comes due Oct 9, 2027. Unpaid by Apr 10, 2028, it lapses early.
- 1 fee due Nov 5, 2027The maintenance fee for Zika Virus Vaccine (US 10,639,365) comes due Nov 5, 2027. Unpaid by May 5, 2028, it lapses early.
Recent changes
Nothing was recorded against this company's patents in the last 90 days.
What they patent
The 5 largest of its 16 families, grouped by real patent family and labeled by the earliest filing in each. No technology classification is inferred from titles.
| MUTANT FRAGMENTS OF OspA AND METHODS AND USES RELATING THERETO | 6 in force | to Mar 2033 |
| Aluminum Compounds for Use in Therapeutics and Vaccines | 6 in force | to Apr 2032 |
| Zika Virus Vaccine | 5 in force | to Dec 2036 |
| Method of Producing Pharmaceutical Compositions Comprising Immunogenic Chikungunya Virus CHIKV-DELTA5NSP3 | 4 in force | to Sep 2038 |
| Mutant Fragments of Ospa and Methods and Uses Relating Thereto | 3 in force | to Jan 2035 |
Patents held now
Soonest term end first.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,568,742 | Methods and Compositions Involving Immunostimulatory Oligodeoxynucleotides held by Valneva Austria GmbH In force · Medium confidence | In force | Medium confidence | |
| US 9,260,694 | Generation of Duck Cell Lines In force · High confidence | In force | High confidence | |
| US 9,884,115 | Aluminum Compounds for Use in Therapeutics and Vaccines held by Valneva Austria GmbH In force · High confidence | In force | High confidence | |
| US 9,895,437 | Aluminum Compounds for Use in Therapeutics and Vaccines held by Valneva Austria GmbH In force · High confidence | In force | High confidence | |
| US 10,668,146 | Methods for Preparing Aluminum Precipitate Compounds for Use in Therapeutics and Vaccines held by Valneva Austria GmbH In force · High confidence | In force | High confidence | |
| US 11,110,170 | Aluminum Compounds for Use in Therapeutics and Vaccines held by Valneva Austria GmbH In force · High confidence | In force | High confidence | |
| US 12,527,863 | Methods for Preparing Aluminum Precipitate Compounds for Use in Therapeutics and Vaccines held by Valneva Austria GmbH In force · High confidence | In force | High confidence | |
| US 9,913,898 | Aluminum Compounds for Use in Therapeutics and Vaccines held by Valneva Austria GmbH In force · High confidence | In force | High confidence | |
| US 8,986,704 | MUTANT FRAGMENTS OF OspA AND METHODS AND USES RELATING THERETO held by Valneva Austria GmbH In force · High confidence | In force | High confidence | |
| US 9,926,343 | Mutant Fragments of Ospa and Methods and Uses Relating Thereto held by Valneva Austria GmbH In force · Medium confidence | In force | Medium confidence |
Also on record, not counted in the 41: 10 patents in force now held by others · 27 patents ended · 14 applications pending · 15 applications abandoned. List them
Sources and methods
Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Fee due within 90 days marks a patent with a maintenance fee due within 90 days of the date this page was computed and not yet recorded paid, so it can end earlier than the bar shows. A fee left unpaid ends the patent at the close of the six month grace period that follows its due date, not on the due date itself. It is not a prediction that the fee will be missed.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.